David A. Siegel Medpace Holdings, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 188,400 shares of MEDP stock, worth $64.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

188,400

Previous 180,300 4.49%

Holding current value

$64.5 Million

Previous $74.3 Million 15.39%

% of portfolio

0.15%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $2.6 Million - $3.7 Million	8,100 Added 4.49%	188,400 $62.8 Million
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $11 Million - $12.5 Million	29,500 Added 19.56%	180,300 $74.3 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $2.05 Million - $2.98 Million	-7,200 Reduced 4.56%	150,800 $60.9 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $6.05 Million - $8.32 Million	-26,600 Reduced 14.41%	158,000 $48.4 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $23.8 Million - $28.7 Million	101,800 Added 122.95%	184,600 $44.7 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $4.08 Million - $5.24 Million	21,800 Added 35.74%	82,800 $19.9 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $5.14 Million - $7.07 Million	29,500 Added 93.65%	61,000 $11.5 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $1.35 Million - $1.99 Million	8,800 Added 38.77%	31,500 $6.69 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $856,267 - $1.08 Million	-5,900 Reduced 20.63%	22,700 $3.57 Million
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $3.05 Million - $3.93 Million	-23,400 Reduced 45.0%	28,600 $4.28 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $4 Million - $6.17 Million	-28,800 Reduced 35.64%	52,000 $8.51 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $4.44 Million - $5.54 Million	24,300 Added 43.01%	80,800 $17.6 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $3.57 Million - $4.16 Million	21,000 Added 59.15%	56,500 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $999,306 - $1.22 Million	6,300 Added 21.58%	35,500 $6.27 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $1.45 Million - $1.85 Million	-11,000 Reduced 27.36%	29,200 $4.79 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $1.4 Million - $1.91 Million	-12,800 Reduced 24.15%	40,200 $5.6 Million
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $27,885 - $39,183	300 Added 0.57%	53,000 $5.92 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $108,928 - $153,088	1,600 Added 3.13%	52,700 $4.9 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $950,334 - $1.57 Million	-15,400 Reduced 23.16%	51,100 $3.75 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $3.11 Million - $3.76 Million	-44,400 Reduced 40.04%	66,500 $5.59 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $193,378 - $266,259	-3,100 Reduced 2.72%	110,900 $9.32 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $3.57 Million - $4.35 Million	-66,500 Reduced 36.84%	114,000 $7.46 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $12.3 Million - $17.5 Million	-248,200 Reduced 57.9%	180,500 $10.6 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $2.29 Million - $3.12 Million	48,800 Added 12.85%	428,700 $22.7 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $5.61 Million - $8.27 Million	129,800 Added 51.9%	379,900 $22.8 Million
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $5.21 Million - $6.96 Million	153,100 Added 157.84%	250,100 $10.8 Million
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $1.49 Million - $1.81 Million	46,462 Added 91.93%	97,000 $3.39 Million
Q4 2017 Feb 14, 2018	BUY	$32.46 - $38.31 $773,781 - $913,233	23,838 Added 89.28%	50,538 $1.83 Million
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $732,381 - $884,037	26,700	26,700 $852,000

Others Institutions Holding MEDP

# of Institutions

618

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account